Company Profile
Nina Capital, founded in 2019 and headquartered in Barcelona, is a specialized venture capital firm investing in early‑stage health technology companies with global ambitions.
The firm focuses on need‑driven founders building innovations in diagnostics, medical devices, clinician training, healthcare infrastructure, and data‑driven clinical pathways. Initial investments range from €200 000 to €1.5 million, with capital reserved for follow‑on rounds.
In early 2025 Nina Capital closed its €50 million Fund III, bringing assets under management to over €100 million. With a portfolio spanning more than 50 companies across Europe, North America, Israel, Canada and Australia, the team applies strategic insight, operational hands‑on support, and a Stanford Biodesign‑inspired methodology to help founders scale.
News & Signals (0)
No linked news activity found for this company.